Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Stroke. 2021 Sep 14;52(10):e635–e645. doi: 10.1161/STROKEAHA.121.035002

Table 1.

Comparison of the mechanism of action, common and major adverse events, and out-of-pocket cost of common anti-platelet medications used in stroke prevention.

Medication Mechanism of action Most common adverse events* Major adverse events Monthly cost**
Cilostazol Reversible intracellular PDE3 inhibition Headache, diarrhea, palpitation, dizziness, tachycardia Contraindicated in patients with heart failure $9.00
Dipyridamole Reversible intracellular PDE5 inhibition Headache, dizziness, abdominal distress, angina pectoris, nausea Major bleeding (when combined with aspirin) $73.54
Aspirin Irreversible extracellular inhibition of COX Dyspepsia, rash, minor bleeding, epistaxis Major bleeding, upper gastrointestinal ulcers $2.47
Clopidogrel Irreversible extracellular inhibition of P2Y12 Bruising, minor bleeding, epistaxis Major bleeding $15.00
Ticagrelor Irreversible extracellular inhibition of P2Y12 Dyspnea, ventricular pause, nausea, dizziness, transient creatinine increase, minor bleeding Major bleeding, bradyarrhythmia, thrombotic thrombocytopenic purpura $373.90
Prasugrel Irreversible extracellular inhibition of P2Y12 Hypertension, headache, nausea, minor bleeding, epistaxis Fatal bleeding, thrombotic thrombocytopenic purpura $32.36
*

According to Lexicomp (online.lexi.com).

**

According to goodrx.com, in the United States, without insurance, at Walmart.